orrigendum to ‘Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update’ [Eur J Cancer 94 (May 2018) 115–125]

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2018-11, Vol.103, p.287
Main Authors: Choueiri, Toni K, Hessel, Colin, Halabi, Susan, Sanford, Ben, Michaelson, M Dror, Hahn, Olwen, Walsh, Meghara, Olencki, Thomas, Picus, Joel, Small, Eric J, Dakhil, Shaker, Feldman, Darren R, Mangeshkar, Milan, Scheffold, Christian, George, Daniel, Morris, Michael J
Format: Article
Language:English
Subjects:
Metastases
Renal cell carcinoma
Survival
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852